Corrigendum to “Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma – Interpretation guidance derived from two randomized EORTC trials” [Lung Cancer 167C (2022) 65–72]

Two figures in the Abstract should read Nausea/vomiting (-14) and Appetite loss (-15) (instead of -1 to 4 and -1 to 5, respectively). One figure in Table 3 (row Nausea and/or vomiting, last column) should read -8 (instead of 8). Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma – Interpretation guidance derived from two randomized EORTC trialsLung CancerVol. 167PreviewA minimally important difference (MID) is the smallest difference in quality of life (QoL) perceived as relevant by patients or clinicians. MIDs aid interpretation of QOL data in research and clinical practice. We aimed to determine MIDs for the EORTC QLQ-C30 for patients with lung cancer or malignant pleural mesothelioma. Full-Text PDF